Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab

NCT05665725 is registered in ClinicalTrials.gov with Timothy Voorhees as lead sponsor.

NCT NCT05665725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05665725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab
Lead sponsor
Timothy Voorhees
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2023
Completion date
September 6, 2024
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-hodgkin lymphoma